Stakeholder Letter to DEA on Ryan Haight Special Registration

FOR YOU:

Stakeholder Letter to DEA on Ryan Haight Special Registration

ATA, along with a number of healthcare stakeholders, submitted a letter with comments on the Drug Enforcement Administration’s (DEA) implementation of a Special Registration provision for telemedicine under the Ryan Haight Act.

Learn more